Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
NEJM Evidence|February 6, 2024
Pharmacologic Thromboprophylaxis for Patients Admitted to General Medicine - Is It Necessary?Michael Fralick, Michelle SholzbergNEJM Evidence|July 22, 2025
Which Patients with Heart Failure Benefit from an SGLT2 Inhibitor?Joseph Benjamen, Michael FralickDiabetologia|January 25, 2021
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievementMichael Fralick, Bernard ZinmanActa Haematologica|December 24, 2025
A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndromePatricia Olar, Stephanie Lee, Michael FralickCanadian Journal of Diabetes|June 12, 2021
Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-AnalysisMichael Colacci, John Fralick, Ayodele Odutayo, et al.Journal of Immigrant and Minority Health|September 5, 2014
Ethnic Differences in Drowning Rates in Ontario, CanadaZane R Gallinger, Michael Fralick, Stephen W HwangPlos One|August 27, 2013
Drowning and the influence of hot weatherMichael Fralick, Christopher J Denny, Donald A RedelmeierThe Canadian Journal of Hospital Pharmacy|April 7, 2022
Nationwide Trends in Dispensing of Sodium Glucose Cotransporter 2 InhibitorsMichael Fralick, Diana Martins, Mina Tadrous, et al.JAMA Internal Medicine|January 8, 2019
Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar AffectMichael Fralick, Chana A Sacks, Aaron S KesselheimPageof 13